PRICE T ROWE HEALTH SCIENCES FUND INC
NSAR-A, EX-27, 2000-08-25
Previous: PRICE T ROWE HEALTH SCIENCES FUND INC, NSAR-A, 2000-08-25
Next: ZORAN CORP DE, 425, 2000-08-25



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0001002624
<NAME> T. ROWE PRICE HEALTH STOCK FUND

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<INVESTMENTS-AT-COST>                           503134
<INVESTMENTS-AT-VALUE>                          664077
<RECEIVABLES>                                    24869
<ASSETS-OTHER>                                     267
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                                  689213
<PAYABLE-FOR-SECURITIES>                         26795
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                         1395
<TOTAL-LIABILITIES>                              28190
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                        459856
<SHARES-COMMON-STOCK>                            30638
<SHARES-COMMON-PRIOR>                            18994
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                           (416)
<ACCUMULATED-NET-GAINS>                          40640
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                        160943
<NET-ASSETS>                                    661022
<DIVIDEND-INCOME>                                 1019
<INTEREST-INCOME>                                 1051
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                    2486
<NET-INVESTMENT-INCOME>                          (416)
<REALIZED-GAINS-CURRENT>                         31062
<APPREC-INCREASE-CURRENT>                        96515
<NET-CHANGE-FROM-OPS>                           127162
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                            0
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                          18559
<NUMBER-OF-SHARES-REDEEMED>                     (6915)
<SHARES-REINVESTED>                                  0
<NET-CHANGE-IN-ASSETS>                          358512
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                        64427
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                             1621
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                   2496
<AVERAGE-NET-ASSETS>                            490592
<PER-SHARE-NAV-BEGIN>                            15.93
<PER-SHARE-NII>                                 (0.01)
<PER-SHARE-GAIN-APPREC>                           5.65
<PER-SHARE-DIVIDEND>                                 0
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              21.57
<EXPENSE-RATIO>                                   1.02


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission